I would love to see clinics offering sampler packs (5 x 1g, 10 x 1g etc) so you can test strains you haven't tried previously without commiting to 10g+ of a single strain, that may turn out to not be beneficial
Second this, it would help new patient like myself find out what works for them faster so it would be beneficial! Personally I don't see it happening though.
I would love to see clinics offering sampler packs (5 x 1g, 10 x 1g etc) so you can test strains you haven't tried previously without commiting to 10g+ of a single strain, that may turn out to not be beneficial
Some do and this is a current issue in MC as clinics seem to be resisting it where as some suppliers are willing and do supply 3.5g and 5g 7g and more are willing if the clinics/pharmacies will accomadate it ,also patients have been crying out for this as we are often left with 9g of expensive unsuited medication.
I'd like to be able to buy in lesser quantities for the purpose of trying out new strains and crosses.
I think sample packs are an excellent idea.
Hopefully this is something that suppliers and dispensaries will look further into as this market develops.
Samples of strains with similar medicinal properties and terpene profiles could be grouped together.
Having a variety of strains available in taster packs would also negate against people accidentally buying "duplicate" strains from ancestral genetics, when buying varieties to fill their prescriptions.
I'd also really like to see some landrace & old school strains being offered.
I'd like to be able to buy in lesser quantities for the purpose of trying out new strains and crosses.
I think sample packs are an excellent idea.
Hopefully this is something that suppliers and dispensaries will look further into as this market develops.
Samples of strains with similar medicinal properties and terpene profiles could be grouped together.
Having a variety of strains available in taster packs would also negate against people accidentally buying "duplicate" strains from ancestral genetics, when buying varieties to fill their prescriptions.
I'd also really like to see some landrace & old school strains being offered.
Sample packs are pretty essential I'd say to stop wastage and keep cost lower and for new patients to find what is suitable and also for new products so people are not taking big financial risks in the context of our budgets when trying them .
A lot of suggestions above that would improve patient experience massively I feel .
As for landraces there are a few available but the quality is often questionable on these products . Hindu Kush Humble Warrior
I was reading about Lyphe, the development of the "V Noidecs" range, all their PR spin and the implications of what they're doing etc....
They cite words including and to the effect of "financial value & surplus stock" in their written blurb (and these are just the particular words I can remember from scrolling at 3 a.m. this morning).
If Lyphe/Noidecs are seemingly creating a market from "leftovers" I'm surmising there's an issue when medical cannabis suppliers/dispensaries have quantities or strains that they find difficult to sell.
From a patient's perspective it makes sense to have taster packs so that people can try different strains and terpene profiles for their different conditions without having to buy quantities of medications not knowing their effect, or from buying quantities and then suffering acclimatisation.
From a business perspective having taster packs would mitigate against "waste, surplus or stock difficult to sell" (after a life of black market cannabis I'm still getting my head around the concept of Waste Cannabis! - I'm sure you'll know what I mean), and a means to market any leftover product after packaging.
The packaging process will affect surplus raw stock levels - but that's only at the place of packaging (a whole other arm of the industry), pre-packaged hard to sell stock left on shelves is another source of lost revenue.
The cynic in me says developing sample packs for patients is unlikely to happen when the market is being run by conglomerate big canna pharma business, unless there's a profit in it for them.
What Lyphe is doing is being falsely marketed as for the patient's benefit, when it clearly isn't.
It's completely detrimental to any future market for independent growers/dispensaries in the UK, and totally undermines the ethos of patient choice, quality standards, traceable origins etc.
It contravenes all the legislation that's in place for any other type of preparation or food product that's for for human consumption, let alone a medicine.
It's evident from reading some of the posts last night particularly around Lyphe Noidecs V range but also Mamedica® supply issues and Curaleaf quality control that there is a need for some "regulation" within the UK industry.
MedBud provides a fantastic platform for us as patients to discuss information freely, share our ideas and experiences of CBPM and to influence this budding industry (no pun intended) to inform the need and lobby for change as well as try to ensure accountability.
We are in the fortunate position as private patients that we have influence in terms of where we spend our money - I feel this is the way to affect change within the industry whilst it's supply chains are in the hands of big business.
In my ideological, blue sky, wishful thinking we'd have a network of small co-operatives, social enterprise and grower owned dispensaries all over the UK that could offer any quantities, as well as direct access pharmacies with staff who know their products.
This CAN happen in the future if we want it and change is slow, but it IS happening in the UK.
I'll try to stop rambling now (my mighty medic arrived this morning, and I just christened it with some RS54 that I'd saved from last year).
- I'm sure you'll know what I mean), and a means to market any leftover product after packaging.
